These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 27028968)

  • 1. Targeting angiogenesis in gastrointestinal tumors: current challenges.
    Nandikolla AG; Rajdev L
    Transl Gastroenterol Hepatol; 2016; 1():67. PubMed ID: 28138633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer and dostarlimab - An episode in discovery to new era of immunotherapy.
    Bethineedi LD; Simhachalam Kutikuppala LV; Boppana SH; Kuchana SK; Kalyani Ponnaganti SV
    J Cancer Res Ther; 2023; 19(5):1490-1491. PubMed ID: 37787342
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives.
    Moehler M; Delic M; Goepfert K; Aust D; Grabsch HI; Halama N; Heinrich B; Julie C; Lordick F; Lutz MP; Mauer M; Alsina Maqueda M; Schild H; Schimanski CC; Wagner AD; Roth A; Ducreux M
    Eur J Cancer; 2016 May; 59():160-170. PubMed ID: 27039171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A paradigm shift from one-size-fits-all to tailor-made therapy for metastatic colorectal cancer.
    Weinberg BA; Marshall JL; Hartley M; Salem ME
    Clin Adv Hematol Oncol; 2016 Feb; 14(2):116-28. PubMed ID: 27057810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel therapeutics in metastatic colorectal cancer: molecular insights and pharmacogenomic implications.
    Hanna DL; Lenz HJ
    Expert Rev Clin Pharmacol; 2016 Aug; 9(8):1091-108. PubMed ID: 27031164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for Non-Small Cell Lung Cancer - Finally a Hint of Hope.
    Recondo G; Recondo G; Galanternik F; Greco M; de la Vega M; E Diaz Cantón ; Valsecchi ME
    Rev Recent Clin Trials; 2016; 11(2):87-92. PubMed ID: 27028969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opportunities for immunotherapy in microsatellite instable colorectal cancer.
    Westdorp H; Fennemann FL; Weren RD; Bisseling TM; Ligtenberg MJ; Figdor CG; Schreibelt G; Hoogerbrugge N; Wimmers F; de Vries IJ
    Cancer Immunol Immunother; 2016 Oct; 65(10):1249-59. PubMed ID: 27060000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-1BB agonism: adding the accelerator to cancer immunotherapy.
    Chester C; Ambulkar S; Kohrt HE
    Cancer Immunol Immunother; 2016 Oct; 65(10):1243-8. PubMed ID: 27034234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy of Colon Cancer.
    Stein A; Folprecht G
    Oncol Res Treat; 2018; 41(5):282-285. PubMed ID: 29705788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Therapy for Colon Cancer.
    Wu C
    Surg Oncol Clin N Am; 2018 Apr; 27(2):235-242. PubMed ID: 29496087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Immunoscore: Colon Cancer and Beyond.
    Angell HK; Bruni D; Barrett JC; Herbst R; Galon J
    Clin Cancer Res; 2020 Jan; 26(2):332-339. PubMed ID: 31413009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA miR-29a Inhibits Colon Cancer Progression by Downregulating B7-H3 Expression: Potential Molecular Targets for Colon Cancer Therapy.
    Wang J; Chen X; Xie C; Sun M; Hu C; Zhang Z; Luan L; Zhou J; Zhou J; Zhu X; Ouyang J; Dong X; Li D; Zhang J; Zhao X
    Mol Biotechnol; 2021 Sep; 63(9):849-861. PubMed ID: 34100183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local immunomodulation combined to radiofrequency ablation results in a complete cure of local and distant colorectal carcinoma.
    Lemdani K; Mignet N; Boudy V; Seguin J; Oujagir E; Bawa O; Peschaud F; Emile JF; Capron C; Malafosse R
    Oncoimmunology; 2019; 8(3):1550342. PubMed ID: 30723580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of Adrenomedullin Aggravates Acute TNBS-Induced Colitis Symptoms in Mice, Especially in Females.
    Martínez-Herrero S; Larrayoz IM; Narro-Íñiguez J; Rubio-Mediavilla S; Martínez A
    Front Physiol; 2017; 8():1058. PubMed ID: 29311984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. What is the Current Role of Immunotherapy for Colon Cancer?
    Galanternik F; Recondo G; Valsecchi ME; Greco M; Recondo G; de la Vega M; E Diaz Cantón
    Rev Recent Clin Trials; 2016; 11(2):93-8. PubMed ID: 27028968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunotherapy in Colorectal Cancer.
    Copur MS
    Oncology (Williston Park); 2019 Oct; 33(10):. PubMed ID: 31661153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COL10A1 is a potential immunotherapy biomarker associated with immune infiltration and deficient mismatch repair in colon cancer.
    Cai S; Sun Z; Yan Y; Li W; Wu Q
    Immunotherapy; 2023 Oct; 15(15):1293-1308. PubMed ID: 37585671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of immunotherapy to treat colorectal cancer.
    Amin M; Lockhart AC
    Expert Opin Investig Drugs; 2015 Mar; 24(3):329-44. PubMed ID: 25519074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of colorectal cancer: Challenges for therapeutic efficacy.
    Ciardiello D; Vitiello PP; Cardone C; Martini G; Troiani T; Martinelli E; Ciardiello F
    Cancer Treat Rev; 2019 Jun; 76():22-32. PubMed ID: 31079031
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.